New combo targets colorectal cancer: serine joins chemo in early trial
NCT ID NCT07178613
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This early-stage trial tests whether adding serine to standard chemotherapy is safe for people with advanced colorectal cancer. About 20 adults will take serine by mouth alongside their usual treatment. The main goal is to check for side effects and find the best dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.